{"schema_version":"secwatch.filing_event.v1","accession":"0001396814-24-000120","form_type":"8-K","ticker":"PCRX","cik":"0001396814","company_name":"Pacira BioSciences, Inc.","filed_at":"2024-09-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.904097+00:00","generated_at":"2026-05-31T05:52:27.299314+00:00","sec_items":["8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Pacira board rejects director Laura Brege's resignation after majority withhold vote","bullets":["Laura Brege received majority withhold votes at 2024 annual meeting; tendered resignation per company policy.","Independent directors unanimously rejected resignation after considering her qualifications, attendance, and prior support.","Brege stepped down from HLS Therapeutics board on Aug 7 to address overboarding; remains Pacira director until 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001396814-24-000120","json":"https://secwatch.observer/filing/0001396814-24-000120.json","markdown":"https://secwatch.observer/filing/0001396814-24-000120.md","text":"https://secwatch.observer/filing/0001396814-24-000120.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000120/0001396814-24-000120-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000120/pcrx-20240903.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:52:27.299314+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}